{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T19:55:30Z","timestamp":1776542130812,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jacep.2019.11.019","type":"journal-article","created":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T14:07:20Z","timestamp":1582726040000},"page":"425-432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Intravenous Sotalol in the Young"],"prefix":"10.1016","volume":"6","author":[{"given":"Alejandro A.","family":"Borquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othman A.","family":"Aljohani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2019.11.019_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0735-1097(93)90821-H","article-title":"Intravenous amiodarone for life-threatening tachyarrhythmias in children and young adults","volume":"22","author":"Perry","year":"1993","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/0735-1097(95)00591-9","article-title":"Pediatric use of intravenous amiodarone: efficacy and safety in critically III patients from a multicenter protocol","volume":"27","author":"Perry","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0002-9149(94)90746-3","article-title":"Clinical efficacy and safety of intravenous amiodarone in infants and children","volume":"74","author":"Figa","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF02310328","article-title":"Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children","volume":"16","author":"Soult","year":"1995","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1067\/mhj.2001.111765","article-title":"Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants","volume":"141","author":"Etheridge","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2019.11.019_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCEP.109.901629","article-title":"Amiodarone versus procainamide for the acute treatment of recurrent supraventricular tachycardia in pediatric patients","volume":"3","author":"Chang","year":"2010","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCEP.110.953356","article-title":"Is it time to tell the emperor he has no clothes?","volume":"3","author":"Saul","year":"2010","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00246-019-02090-7","article-title":"Cardiovascular collapse with intravenous amiodarone in children: a multi-center retrospective cohort study","volume":"40","author":"Maghrabi","year":"2019","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib9","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s00246-017-1683-9","article-title":"Pediatric dosing of intravenous sotalol based on body surface area in patients with arrhythmia","volume":"38","author":"Li","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib10","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/j.hrthm.2018.07.010","article-title":"Early experience with intravenous sotalol in children with and without congenital heart disease","volume":"15","author":"Vald\u00e9s","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2019.11.019_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mcp.2001.113795","article-title":"Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia","volume":"69","author":"Saul","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacep.2019.11.019_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9149(90)90196-8","article-title":"Pharmacology, pharmacodynamics and pharmacokinetics of sotalol","volume":"65","author":"Antonaccio","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijcard.2008.04.060","article-title":"Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol","volume":"136","author":"Rao","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.hlc.2018.03.017","article-title":"The use of intravenous sotalol in cardiac arrhythmias","volume":"27","author":"Samanta","year":"2018","journal-title":"Hear Lung Circ"},{"key":"10.1016\/j.jacep.2019.11.019_bib16","doi-asserted-by":"crossref","first-page":"19A","DOI":"10.1016\/0002-9149(93)90021-4","article-title":"Clinical pharmacokinetics of sotalol","volume":"72","author":"Hanyok","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/MJT.0b013e3181ea3184","article-title":"Developing a safe intravenous sotalol dosing regimen","volume":"17","author":"Somberg","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.jacep.2019.11.019_bib18","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/0735-1097(95)00268-3","article-title":"Efficacy and proarrhythmia of oral sotalol in pediatric patients","volume":"26","author":"Pfammatter","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000316050","article-title":"QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol","volume":"116","author":"Somberg","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.jacep.2019.11.019_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1553-2712.2001.tb01275.x","article-title":"Meta-analysis of the risk of Torsades de pointes in patients treated with intravenous racemic sotalol","volume":"8","author":"Marill","year":"2001","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacep.2019.11.019_bib21","first-page":"332","article-title":"Use of intravenous sotalol in newborns with supraventricular tachycardia","volume":"3","author":"Kim","year":"2017","journal-title":"Heart Case Rep"},{"key":"10.1016\/j.jacep.2019.11.019_bib22","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.amjcard.2017.01.034","article-title":"Efficacy of intravenous sotalol for treatment of incessant tachyarrhythmias in children","volume":"119","author":"Li","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib23","first-page":"117","article-title":"Intravenous sotalol for conversion of atrial flutter in infants","volume":"4","author":"Aljohani","year":"2018","journal-title":"Hear Case Rep"},{"key":"10.1016\/j.jacep.2019.11.019_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00246-011-0010-0","article-title":"High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias","volume":"32","author":"Knudson","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib25","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1017\/S1047951117001408","article-title":"Intravenous sotalol use in a complex critically ill child: balancing the systems in choosing antiarrhythmic medication","volume":"27","author":"Pasierb","year":"2017","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jacep.2019.11.019_bib26","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury 2012","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jacep.2019.11.019_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s002469900104","article-title":"New antiarrhythmic drug in pediatric use: sotalol","volume":"18","author":"Pfammatter","year":"1997","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib28","first-page":"35","article-title":"Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and\/or ventricular tachyarrhythmia","volume":"41","author":"Melikian","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacep.2019.11.019_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0002-8703(97)70224-2","article-title":"Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis","volume":"133","author":"Casey","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2019.11.019_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00246-003-0226-8","article-title":"Neonatal intractable atrial flutter successfully treated with intravenous flecainide","volume":"25","author":"Suzumura","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jacep.2019.11.019_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00838781","article-title":"Amiodarone therapy of intractable atrial flutter in a premature hydropic\u00a0neonate","volume":"13","author":"Hijazi","year":"1992","journal-title":"Pediatr Cardiol"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19309478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X19309478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:28:00Z","timestamp":1762500480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X19309478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2405500X19309478"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2019.11.019","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Sotalol in the Young","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2019.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}